1449P The preliminary data from a single-arm, open-label, multicenter phase II clinical trial: KN046 combined with axitinib as first-line (1L) treatment for NSCLC

Y. Zhao,Y. Huang, W. Fang,Y. Yang, J. Shi, H. Zhao, X. Meng, L. Zhang, A. Liu, T. Xu,Y. Liu, N. Wang, L. Zhang

Annals of Oncology(2023)

引用 0|浏览2
暂无评分
关键词
nsclc,axitinib,clinical trial,treatment,single-arm,open-label,first-line
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要